193 participants
RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-09-05
- Start Date:
- 2021-04-21
- Completion:
- 2023-08-11
Conditions
- Primary Biliary Cholangitis
Interventions
- DRUG